These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15934617)

  • 1. Investigation of the effect of pamidronate disodium on the in vitro viability of osteosarcoma cells from dogs.
    Ashton JA; Farese JP; Milner RJ; Lee-Ambrose LM; van Gilder JM
    Am J Vet Res; 2005 May; 66(5):885-91. PubMed ID: 15934617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the effects of deracoxib and piroxicam on the in vitro viability of osteosarcoma cells from dogs.
    Royals SR; Farese JP; Milner RJ; Lee-Ambrose L; van Gilder J
    Am J Vet Res; 2005 Nov; 66(11):1961-7. PubMed ID: 16334957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the bisphosphonate alendronate on viability of canine osteosarcoma cells in vitro.
    Farese JP; Ashton J; Milner R; Ambrose LL; Van Gilder J
    In Vitro Cell Dev Biol Anim; 2004; 40(3-4):113-7. PubMed ID: 15311969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.
    McMahon MB; Bear MD; Kulp SK; Pennell ML; London CA
    Am J Vet Res; 2010 Jul; 71(7):799-808. PubMed ID: 20594083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bisphosphonate pamidronate is a potent inhibitor of human osteosarcoma cell growth in vitro.
    Sonnemann J; Eckervogt V; Truckenbrod B; Boos J; Winkelmann W; van Valen F
    Anticancer Drugs; 2001 Jun; 12(5):459-65. PubMed ID: 11395574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activity of dihydroartemisinin in canine osteosarcoma cell lines.
    Hosoya K; Murahari S; Laio A; London CA; Couto CG; Kisseberth WC
    Am J Vet Res; 2008 Apr; 69(4):519-26. PubMed ID: 18380584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain.
    Fan TM; de Lorimier LP; O'Dell-Anderson K; Lacoste HI; Charney SC
    J Vet Intern Med; 2007; 21(3):431-9. PubMed ID: 17552447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of intravenous pamidronate administration in 33 cancer-bearing dogs with primary or secondary bone involvement.
    Fan TM; de Lorimier LP; Charney SC; Hintermeister JG
    J Vet Intern Med; 2005; 19(1):74-80. PubMed ID: 15715051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of effects of radiation therapy combined with either pamidronate or zoledronate on canine osteosarcoma cells.
    Hoddinott K; Oblak ML; Wood GA; Boston S; Mutsaers AJ
    Can J Vet Res; 2019 Jan; 83(1):3-10. PubMed ID: 30670896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the protective effects of all-trans-astaxanthin on canine osteosarcoma cell lines.
    Wakshlag JJ; Balkman CA; Morgan SK; McEntee MC
    Am J Vet Res; 2010 Jan; 71(1):89-96. PubMed ID: 20043787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of pamidronate disodium to reduce cholecalciferol-induced toxicosis in dogs.
    Rumbeiha WK; Fitzgerald SD; Kruger JM; Braselton WE; Nachreiner R; Kaneene JB; Frese KK
    Am J Vet Res; 2000 Jan; 61(1):9-13. PubMed ID: 10630770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bisphosphonate pamidronate is a potent inhibitor of Ewing's sarcoma cell growth in vitro.
    Sonnemann J; Eckervogt V; Truckenbrod B; Boos J; Winkelmann W; van Valen F
    Anticancer Drugs; 2003 Oct; 14(9):767-71. PubMed ID: 14551512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of pamidronate and chemotherapy on survival times in dogs with appendicular primary bone tumors treated with palliative radiation therapy.
    Oblak ML; Boston SE; Higginson G; Patten SG; Monteith GJ; Woods JP
    Vet Surg; 2012 Apr; 41(3):430-5. PubMed ID: 23253085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind placebo-controlled trial of adjuvant pamidronate with palliative radiotherapy and intravenous doxorubicin for canine appendicular osteosarcoma bone pain.
    Fan TM; Charney SC; de Lorimier LP; Garrett LD; Griffon DJ; Gordon-Evans WJ; Wypij JM
    J Vet Intern Med; 2009; 23(1):152-60. PubMed ID: 19175734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of timing of bisphosphonate administration on canine osteosarcoma cells undergoing radiation therapy.
    Hoddinott K; Oblak ML; Wood GA; Boston S; Mutsaers AJ
    Can J Vet Res; 2020 Jul; 84(3):225-229. PubMed ID: 32801458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line.
    Mackie PS; Fisher JL; Zhou H; Choong PF
    Br J Cancer; 2001 Apr; 84(7):951-8. PubMed ID: 11286476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17-AAG and Apoptosis, Autophagy, and Mitophagy in Canine Osteosarcoma Cell Lines.
    Massimini M; Palmieri C; De Maria R; Romanucci M; Malatesta D; De Martinis M; Maniscalco L; Ciccarelli A; Ginaldi L; Buracco P; Bongiovanni L; Della Salda L
    Vet Pathol; 2017 May; 54(3):405-412. PubMed ID: 28438108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro retinoid-induced growth inhibition and morphologic differentiation of canine osteosarcoma cells.
    Hong SH; Kadosawa T; Nozaki K; Mochizuki M; Matsunaga S; Nishimura R; Sasaki N
    Am J Vet Res; 2000 Jan; 61(1):69-73. PubMed ID: 10630782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldoxorubicin-loaded nanofibers are cytotoxic for canine mammary carcinoma and osteosarcoma cell lines in vitro: A short communication.
    Stokol T; Wan C; Blakely R; Bellat V; Law B
    Res Vet Sci; 2020 Feb; 128():86-89. PubMed ID: 31760317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tyrosine kinase inhibitor sorafenib decreases cell number and induces apoptosis in a canine osteosarcoma cell line.
    Wolfesberger B; Tonar Z; Gerner W; Skalicky M; Heiduschka G; Egerbacher M; Thalhammer JG; Walter I
    Res Vet Sci; 2010 Feb; 88(1):94-100. PubMed ID: 19665156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.